Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-15 Purchase | 2026-06-17 6:24 pm | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 67,669 | $24.97 | $1,689,818 | 7,808,627 (Indirect) | View |
| 2026-06-12 Purchase | 2026-06-16 6:08 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 531,326 | $8.6574 | $4,599,903 | 17,922,766 (Indirect) | View |
| 2026-06-12 Sale | 2026-06-16 6:01 pm | Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 448,836 | $0.38713 | $173,758 | 331,414 (Indirect) | View |
| 2026-06-11 Purchase | 2026-06-15 6:57 pm | Parabilis Medicines Inc. | PBLS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 21,188,750 | $20 | $423,775,000 | 2,648,278 (Indirect) | View |
| 2026-06-09 Sale | 2026-06-11 8:13 pm | Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 678,226 | $0.37387 | $253,569 | 361,229 (Indirect) | View |
| 2026-06-09 Purchase | 2026-06-11 7:36 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,027,722 | $7.4438 | $7,650,148 | 17,391,440 (Indirect) | View |
| 2026-05-19 Purchase | 2026-05-21 4:20 pm | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 4,798 | $24.96 | $119,776 | 7,740,958 (Indirect) | View |
| 2026-05-12 Purchase | 2026-05-14 5:21 pm | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 6,387 | $24.9 | $159,036 | 7,736,160 (Indirect) | View |
| 2026-05-11 Purchase | 2026-05-13 5:45 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 6,510,416 | $11.52 | $74,999,992 | 18,533,856 (Indirect) | View |
| 2026-05-08 Sale | 2026-05-12 6:26 pm | Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 565,167 | $0.69128 | $390,688 | 406,282 (Indirect) | View |
| 2026-05-07 Purchase | 2026-05-11 5:44 pm | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 51,258 | $24.75 | $1,268,594 | 7,729,773 (Indirect) | View |
| 2026-05-04 Purchase | 2026-05-06 7:16 pm | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. RA Capital Nexus Fund IV L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2,840,429 | $18.39 | $52,222,946 | 6,314,525 (Indirect) | View |
| 2026-04-22 Sale | 2026-04-24 6:12 pm | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 165,150 | $15.77 | $2,604,416 | 2,402,095 (Indirect) | View |
| 2026-04-17 Sale | 2026-04-21 7:04 pm | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 630,374 | $16.14 | $10,174,788 | 2,567,245 (Indirect) | View |
| 2026-04-13 Sale | 2026-04-15 5:29 pm | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 737,989 | $16.1 | $11,883,340 | 3,197,619 (Indirect) | View |
| 2026-02-18 Purchase | 2026-04-13 5:20 pm | Adicet Bio Inc. | ACET | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 223,596 | $7.1734 | $1,603,934 | 1,182,624 (Indirect) | View |
| 2026-04-08 Sale | 2026-04-10 6:23 pm | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 620,133 | $16.5 | $10,233,811 | 3,935,608 (Indirect) | View |
| 2026-04-02 Sale | 2026-04-06 6:51 pm | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 849,257 | $17.1 | $14,518,963 | 4,555,741 (Indirect) | View |
| 2026-03-27 Purchase | 2026-03-31 4:15 pm | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 369,000 | $23.75 | $8,762,797 | 7,692,750 (Indirect) | View |
| 2026-03-26 Purchase | 2026-03-30 8:30 pm | Wave Life Sciences Ltd. | WVE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 8,772,496 | $6.2268 | $54,624,378 | 27,004,320 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-17 Option Award | 2026-06-18 5:41 pm | N/A 2036-06-16 | Sionna Therapeutics Inc. | SION | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 17,340 | $0 | 17,340 (Indirect) | View |
| 2026-06-15 Option Award | 2026-06-15 8:22 pm | N/A 2036-06-15 | LENZ Therapeutics Inc. | LENZ | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 22,100 | $0 | 22,100 (Indirect) | View |
| 2026-06-11 Conversion | 2026-06-15 6:57 pm | N/A N/A | Parabilis Medicines Inc. | PBLS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 19,659,625 | $0 | 2,648,278 (Indirect) | View |
| 2026-06-11 Option Award | 2026-06-12 8:44 pm | N/A 2036-06-10 | Vor Biopharma Inc. | VOR | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 57,162 | $0 | 57,162 (Indirect) | View |
| 2026-06-11 Option Award | 2026-06-12 8:30 pm | N/A 2036-06-10 | Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 21,000 | $0 | 11,216,943 (Indirect) | View |
| 2026-06-09 Option Award | 2026-06-11 6:36 pm | N/A 2036-06-08 | Parabilis Medicines Inc. | PBLS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 20,215 | $0 | 20,215 (Indirect) | View |
| 2026-06-10 Option Award | 2026-06-11 4:30 pm | N/A 2036-06-09 | Nkarta Inc. | NKTX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 37,000 | $0 | 37,000 (Indirect) | View |
| 2026-06-09 Option Award | 2026-06-10 4:43 pm | N/A 2036-06-09 | Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 19,475 | $0 | 19,475 (Indirect) | View |
Ownership | 2026-06-09 9:30 pm | N/A N/A | Parabilis Medicines Inc. | PBLS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 0 | $0 | 7,744,621 (Indirect) | View |
| 2026-06-05 Option Award | 2026-06-08 6:57 pm | N/A 2036-06-04 | Climb Bio Inc. | CLYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 40,000 | $0 | 40,000 (Indirect) | View |
| 2026-06-03 Option Award | 2026-06-05 5:12 pm | N/A 2036-06-03 | Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 88,750 | $0 | 21,094,219 (Indirect) | View |
| 2026-05-28 Option Award | 2026-06-01 5:45 pm | N/A 2036-05-27 | Tyra Biosciences Inc. | TYRA | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 13,160 | $0 | 13,160 (Indirect) | View |
| 2026-05-18 Option Award | 2026-05-20 4:59 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 9,366 | $0 | 12,238,762 (Indirect) | View |
| 2026-05-04 Conversion | 2026-05-06 7:16 pm | N/A N/A | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. RA Capital Nexus Fund IV L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 5,057,999 | $0 | 6,314,525 (Indirect) | View |
Ownership | 2026-04-30 6:36 pm | N/A N/A | Hemab Therapeutics Holdings Inc. | COAG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. RA Capital Nexus Fund IV L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 0 | $0 | 4,838,086 (Indirect) | View |
| 2026-04-29 Option Award | 2026-04-29 6:46 pm | N/A N/A | Climb Bio Inc. | CLYM | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund II L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2,106,000 | $9.4999 | 22,546,000 (Indirect) | View |
| 2026-04-27 Other | 2026-04-29 4:15 pm | N/A N/A | Adicet Bio Inc. | ACET | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 250,000 | $0 | 2,585,457 (Indirect) | View |
| 2026-04-27 Other | 2026-04-28 5:14 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 1,407,000 | $0 | 9,289,882 (Indirect) | View |
Ownership | 2026-04-28 5:13 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 0 | $0 | 7,882,882 (Indirect) | View |
| 2026-04-22 Option Award | 2026-04-23 4:28 pm | N/A N/A | Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 3,888,888 | $1.8 | 12,229,396 (Indirect) | View |
Ownership | 2026-04-13 5:19 pm | N/A N/A | Adicet Bio Inc. | ACET | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 0 | $0 | 2,111,861 (Indirect) | View |
| 2026-03-16 Option Award | 2026-03-18 4:15 pm | N/A N/A | Acumen Pharmaceuticals Inc. | ABOS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 6,060,606 | $3.3 | 20,992,669 (Indirect) | View |